ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,263Medicare Part D Prescriptions Filled, Including Refills

Rank: 28 out of 247

$560K Total Retail Price of All Prescriptions

Rank: 38 out of 247

350 Patients Receiving at Least One Drug in Part D
74% Patients 65 Years and Older
70% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in New Mexico
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

6% of this provider’s 350 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

16% of this provider’s 350 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
LISINOPRIL 486 310 92 1 2
METFORMIN HCL 391 295 66 2 6
LEVOTHYROXINE SODIUM 374 254 66 3 1
AMLODIPINE BESYLATE 321 245 63 4 4
HYDROCODONE-ACETAMINOPHEN 260 153 54 S3 5 7
OMEPRAZOLE 222 141 53 6 5
WARFARIN SODIUM 209 161 27 7 16
ALPRAZOLAM 208 133 42 B 8 26
SIMVASTATIN 198 179 37 9 3
ATORVASTATIN CALCIUM 196 143 31 10 8
LOVASTATIN 196 119 30 10 15
PREDNISONE 191 137 58 12 37
CARVEDILOL 182 138 29 13 31
PRAVASTATIN SODIUM 167 94 37 14 27
FUROSEMIDE 165 128 33 15 9
CEFDINIR 144 127 76 16 198
GABAPENTIN 131 112 28 17 11
SERTRALINE HCL 126 96 17 18 24
CLOPIDOGREL 123 105 23 19 29
HYDROCHLOROTHIAZIDE 123 89 24 19 10
POTASSIUM CHLORIDE 116 81 27 21 17
FAMOTIDINE* 111 71 25 22 81
TERAZOSIN HCL 109 104* 18 23 90
TAMSULOSIN HCL 105 100* 24 24 21
CLONIDINE HCL 104 89 19 25 80
AZITHROMYCIN 100 54 58 26 56
LOSARTAN POTASSIUM 98 52 19 27 12
GLYBURIDE 96 83 16 R 28 78
LEVOFLOXACIN 92 78 43 29 117
RANITIDINE HCL 91 35 14 30 35
ADVAIR DISKUS 89 41 28 31 58
METOPROLOL SUCCINATE 87 46 18 32 14
ESCITALOPRAM OXALATE 85 80* 14 33 72
JANUVIA 85 80* 17 33 48
NEXIUM 84 79* 18 35 55
AMOX TR-POTASSIUM CLAVULANATE 83 43 47 36 106
PROAIR HFA 81 35 24 37 41
LABETALOL HCL 80 57 17 38 130
ATENOLOL 77 72* 17 39 20
ALLOPURINOL 70 57 16 40 30
MECLIZINE HCL 70 54 34 40 153
METOPROLOL TARTRATE 66 51 13 42 13
LANTUS 66 52 13 42 47
IBUPROFEN 66 45 29 42 50
FLUTICASONE PROPIONATE 64 51 26 45 19
PATANOL 63 22 25 46 245
MIRTAZAPINE 59 45 16 47 45
OXYCODONE-ACETAMINOPHEN 57 46 13 S2 48 54
HYDRALAZINE HCL 57 43 12 48 88
TEMAZEPAM 56 42 19 B 50 73
BENICAR 56 51* 16 50 176
FLUNISOLIDE 52 22 31 52 189
CEFPROZIL 52 23 25 52 277
DIOVAN 50 <11 <11 54 51
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 4, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.